115 related articles for article (PubMed ID: 37356935)
41. Enhanced Detection of Genitourinary Cancers Using Fragmentation and Copy Number Profiles Obtained from Urinary Cell-Free DNA.
Han Y; Li X; Zhang M; Yang Y; Ge G; Wang K; Gong Y; Liang Y; Niu H; Ci W
Clin Chem; 2021 Jan; 67(2):394-403. PubMed ID: 33523215
[TBL] [Abstract][Full Text] [Related]
42. High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.
Kreisel F; Kulkarni S; Kerns RT; Hassan A; Deshmukh H; Nagarajan R; Frater JL; Cashen A
Cancer Genet; 2011 Mar; 204(3):129-37. PubMed ID: 21504712
[TBL] [Abstract][Full Text] [Related]
43. Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration.
Jiang XF; Zhang BM; Du FQ; Guo JN; Wang D; Li YE; Deng SH; Cui BB; Liu YL
Front Immunol; 2022; 13():1013828. PubMed ID: 36569844
[TBL] [Abstract][Full Text] [Related]
44. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
[TBL] [Abstract][Full Text] [Related]
45. Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Cherng HJ; Sun R; Sugg B; Irwin R; Yang H; Le CC; Deng Q; Fayad L; Fowler NH; Parmar S; Steiner R; Hagemeister F; Nair R; Lee HJ; Rodriguez M; Samaniego F; Iyer SP; Flowers CR; Wang L; Nastoupil LJ; Neelapu SS; Ahmed S; Strati P; Green MR; Westin J
Blood; 2022 Aug; 140(5):504-515. PubMed ID: 35512184
[TBL] [Abstract][Full Text] [Related]
46. Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers.
Chang Y; Li S; Li Z; Wang X; Chang F; Geng S; Zhu D; Zhong G; Wu W; Chang Y; Tu S; Mao M
Front Oncol; 2024; 14():1341997. PubMed ID: 38313801
[TBL] [Abstract][Full Text] [Related]
47. Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma.
Dong X; Chen G; Huang X; Li Z; Peng F; Chen H; Zhou Y; He L; Qiu L; Cai Z; Liu J; Liu X
Mol Oncol; 2022 May; 16(10):1986-1999. PubMed ID: 34939323
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract][Full Text] [Related]
49. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
50. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
[TBL] [Abstract][Full Text] [Related]
51. Clinical Utility of Cell-Free DNA for the Detection of
McCoach CE; Blakely CM; Banks KC; Levy B; Chue BM; Raymond VM; Le AT; Lee CE; Diaz J; Waqar SN; Purcell WT; Aisner DL; Davies KD; Lanman RB; Shaw AT; Doebele RC
Clin Cancer Res; 2018 Jun; 24(12):2758-2770. PubMed ID: 29599410
[No Abstract] [Full Text] [Related]
52. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
[TBL] [Abstract][Full Text] [Related]
53. MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma.
Lu TX; Fan L; Wang L; Wu JZ; Miao KR; Liang JH; Gong QX; Wang Z; Young KH; Xu W; Zhang ZH; Li JY
Oncotarget; 2015 Jul; 6(21):18374-88. PubMed ID: 26158410
[TBL] [Abstract][Full Text] [Related]
54. A pilot prospective study of plasma cell-free DNA whole-genome sequencing identified chromosome 7p copy number gains as a specific biomarker for early lung cancer detection.
Yu HJ; Yu XJ; Tang J; Lu X; Ma HT
Neoplasma; 2021 May; 68(3):567-571. PubMed ID: 33618519
[TBL] [Abstract][Full Text] [Related]
55. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
[TBL] [Abstract][Full Text] [Related]
56. Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.
Nakabayashi M; Kawashima A; Yasuhara R; Hayakawa Y; Miyamoto S; Iizuka C; Sekizawa A
Sci Rep; 2018 Jul; 8(1):11205. PubMed ID: 30046040
[TBL] [Abstract][Full Text] [Related]
57. Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
Brusselaers N; Ekwall K; Durand-Dubief M
Hum Genomics; 2019 Nov; 13(1):54. PubMed ID: 31699156
[TBL] [Abstract][Full Text] [Related]
58. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
59. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
[TBL] [Abstract][Full Text] [Related]
60. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
